Phibro Animal Health Corporation
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -45.8% | +164.4% | -28.9% | -32.6% | +25.8% | -18.6% | -34.5% | -57.9% | +558.1% | -8.5% | -13.9% | |
| – | +8.6% | +10.9% | +3.6% | +2.3% | +17.3% | -1.4% | +2.6% | +4.0% | +6.4% | +26.1% | +13.0% | |
| – | – | – | – | +576.3% | +0.0% | -50.0% | -100.0% | – | – | +50.9% | +122.7% | |
| – | -2,148.1% | – | +74.3% | -100.6% | – | -203.1% | – | – | – | – | – | |
| – | – | – | -2,519.9% | – | – | – | – | – | – | -165.1% | – | |
| – | +81.2% | -42.5% | -11.3% | +61.2% | +13.9% | -13.9% | +26.3% | +39.8% | -20.4% | -7.1% | +54.3% | |
| – | +140.2% | -73.5% | +286.4% | -83.3% | +751.8% | -84.6% | +21.5% | +227.8% | -34.9% | +499.0% | -75.2% | |
| – | +0.7% | +0.8% | +1.6% | +15.7% | +4.4% | +0.1% | +0.1% | +0.0% | +0.0% | +0.0% | +0.1% | |
| – | +201.1% | +11,861.7% | -98.8% | -80.1% | – | – | – | – | – | – | – | |
| – | – | -170.0% | -96.8% | – | +352.1% | -91.1% | +830.2% | -17.6% | -69.2% | +1,757.4% | -94.6% | |
| – | – | -206.7% | -78.1% | -65.1% | – | -141.5% | – | +65.1% | -125.1% | – | -103.2% | |
| – | -74.8% | +412.1% | -219.7% | – | -174.7% | – | +73.3% | -237.2% | – | -108.8% | – | |
| – | -98.2% | +8,849.2% | -33.6% | -66.4% | +46.4% | -25.0% | -128.4% | – | – | -9.8% | -76.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.